Literature DB >> 23055001

Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response.

Marie-Ève Fortier1, Sarojini M Sengupta, Natalie Grizenko, Zia Choudhry, Geeta Thakur, Ridha Joober.   

Abstract

Exposure to stressors results in a spectrum of autonomic, endocrine, and behavioral responses. A key pathway in this response to stress is the hypothalamic-pituitary-adrenal (HPA) axis, which results in a transient increase in circulating cortisol, which exerts its effects through the two related ligand-activated transcription factors: the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR). Genetic polymorphisms in these receptors have been shown to influence HPA axis reactivity, and chronic dysregulation of the HPA axis has been associated with the development of several psychiatric disorders. The objective of the study was to test the association between four functional polymorphisms in NR3C1 (encoding GR: ER22/23EK-rs6189, N363S-rs6195, BclI-rs41423247, A3669G-rs6198) and two in NR3C2 (encoding MR: 215G/C-rs2070951, I180 V-rs5522) with childhood ADHD. Family-based association tests (FBAT) were conducted with the categorical diagnosis of ADHD, behavioral and cognitive phenotypes related to ADHD, as well as with treatment response assessed in a 2-week, double-blind, placebo-controlled trial with methylphenidate. A specific haplotype (G:A:G:G; ER22/23EK- N363S- BclI- A3669G) of NR3C1 showed a significant association with behaviors related to ADHD (particularly thought and attention problems, aggressive behavior), comorbidity with oppositional defiant disorder, and executive function domains. An association was also observed with treatment response (assessed by the Conners'-Teachers and Restricted Academic Situation Scale). In contrast, MR gene polymorphisms were not associated with any of the variables tested. To the best of our knowledge, this is the first report showing an association between functional polymorphisms in NR3C1 and ADHD, providing genetic evidence for involvement of the HPA axis in the disorder and treatment response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055001     DOI: 10.1007/s12017-012-8202-1

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  57 in total

1.  Human mineralocorticoid receptor (MR) gene haplotypes modulate MR expression and transactivation: implication for the stress response.

Authors:  Nienke van Leeuwen; Silja Bellingrath; E Ronald de Kloet; Frans G Zitman; Roel H DeRijk; Brigitte M Kudielka; Stefan Wüst
Journal:  Psychoneuroendocrinology       Date:  2010-11-20       Impact factor: 4.905

2.  Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

3.  The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting.

Authors:  C Kirschbaum; K M Pirke; D H Hellhammer
Journal:  Neuropsychobiology       Date:  1993       Impact factor: 2.328

4.  Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals.

Authors:  N A Huizenga; J W Koper; P de Lange; H A Pols; R P Stolk; D E Grobbee; F H de Jong; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

Review 5.  Attention-deficit hyperactivity disorder.

Authors:  Joseph Biederman; Stephen V Faraone
Journal:  Lancet       Date:  2005 Jul 16-22       Impact factor: 79.321

Review 6.  The origin and functions of multiple human glucocorticoid receptor isoforms.

Authors:  Nick Z Lu; John A Cidlowski
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

7.  The stress response in adolescents with inattentive type ADHD symptoms.

Authors:  William T Randazzo; Samantha Dockray; Elizabeth J Susman
Journal:  Child Psychiatry Hum Dev       Date:  2007-06-13

Review 8.  The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition.

Authors:  S J Lupien; F Maheu; M Tu; A Fiocco; T E Schramek
Journal:  Brain Cogn       Date:  2007-04-26       Impact factor: 2.310

9.  Attention-deficit hyperactivity disorder and the stress response.

Authors:  J A King; R A Barkley; S Barrett
Journal:  Biol Psychiatry       Date:  1998-07-01       Impact factor: 13.382

10.  Salivary testosterone and cortisol in disruptive children: relationship to aggressive, hyperactive, and internalizing behaviors.

Authors:  A S Scerbo; D J Kolko
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994-10       Impact factor: 8.829

View more
  11 in total

1.  MR and GR functional SNPs may modulate tobacco smoking susceptibility.

Authors:  Diego L Rovaris; Nina R Mota; Lucas A de Azeredo; Renata B Cupertino; Guilherme P Bertuzzi; Evelise R Polina; Verônica Contini; Gustavo L Kortmann; Eduardo S Vitola; Eugenio H Grevet; Rodrigo Grassi-Oliveira; Sidia M Callegari-Jacques; Claiton H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2013-03-31       Impact factor: 3.575

2.  Facing the Methodological Challenge in Dissecting the Genetics of ADHD: A Case for Deep Phenotyping and Heterogeneity Reduction.

Authors:  Sarojini M Sengupta; Natalie Grizenko; Marie-Ève Fortier; Marina Ter-Stepanian; Ridha Joober
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2020-08-01

Review 3.  Prenatal Alcohol Exposure in Rodents As a Promising Model for the Study of ADHD Molecular Basis.

Authors:  Argelia E Rojas-Mayorquín; Edgar Padilla-Velarde; Daniel Ortuño-Sahagún
Journal:  Front Neurosci       Date:  2016-12-15       Impact factor: 4.677

4.  Predicting attention-deficit/hyperactivity disorder severity from psychosocial stress and stress-response genes: a random forest regression approach.

Authors:  D van der Meer; P J Hoekstra; M van Donkelaar; J Bralten; J Oosterlaan; D Heslenfeld; S V Faraone; B Franke; J K Buitelaar; C A Hartman
Journal:  Transl Psychiatry       Date:  2017-06-06       Impact factor: 6.222

5.  Childhood Trajectories of Hyperactivity/Inattention Symptoms and Diurnal Cortisol in Middle Adolescence: Results from a UK Birth Cohort.

Authors:  Dongying Ji; Eirini Flouri; Efstathios Papachristou; Marta Francesconi
Journal:  J Atten Disord       Date:  2021-08-11       Impact factor: 3.256

Review 6.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25

7.  HPA axis genetic variation, cortisol and psychosis in major depression.

Authors:  A F Schatzberg; J Keller; L Tennakoon; A Lembke; G Williams; F B Kraemer; J E Sarginson; L C Lazzeroni; G M Murphy
Journal:  Mol Psychiatry       Date:  2013-10-29       Impact factor: 15.992

8.  Nr3C1-Bhlhb2 Axis Dysregulation Is Involved in the Development of Attention Deficit Hyperactivity.

Authors:  Li Hui Wu; Wei Cheng; Mei Yu; Bao Mei He; Hui Sun; Qi Chen; Yi Wei Dong; Xiao Ting Shao; Qian Qian Cai; Min Peng; Xing Zhong Wu
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

9.  HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition.

Authors:  J Keller; R Gomez; G Williams; A Lembke; L Lazzeroni; G M Murphy; A F Schatzberg
Journal:  Mol Psychiatry       Date:  2016-08-16       Impact factor: 15.992

10.  Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents With Congenital Adrenal Hyperplasia.

Authors:  Lauren A Harasymiw; Scott D Grosse; Kyriakie Sarafoglou
Journal:  J Endocr Soc       Date:  2020-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.